Expressions of Interest are due to Ontario Genomics on May 15th.

GAPP is a Genome Canada funding program for Receptors (such as industry, government, not-for-profit, other organizations) working with an academic partner to validate an ‘omics-driven technology.

The GAPP Aims To

Accelerate the application of Canadian genomics-derived solutions to real-world opportunities and challenges defined by industry and public sector Receptors.
Channel Canada’s genomics capacity into sustainable innovations that benefit Canadians.
Enhance the value of Canadian genomics technologies by de-risking and incentivizing follow-on investment from industry and other partners.
Foster mutually beneficial collaboration and knowledge exchange between Canadian academia and technology receptors.

For examples of previously funded projects, see Funded GAPP Projects

Key Parameters of the Program

Total project size: $300,000 to $6 million.
Co-Funding: 1/3 investment from Genome Canada, 1/3 provided by the Receptor partner (cash or in-kind) and 1/3 of other co-funding (non-GC). For more information see Section 9 and Appendix 2 of the GAPP Investment Strategy and Guidelines.
Project term: 1 – 3 years. Shorter or longer terms will be considered only if strong rationale is provided.
Project stage: Small-scale proof-of-concept / pilot projects through to large-scale projects will be accepted. Projects should not be in discovery phase.

Project Eligibility

To be eligible for the GAPP, a project must:

Develop and apply a genomics-derived tool, product or process to an opportunity or challenge defined by the Receptor(s);
Focus on late stage R&D that will position the innovation for near-term implementation / commercialization;
Be co-led by an academic and a Receptor organization in partnership, with active and necessary roles for both; and
Demonstrate the potential to generate significant social and/or economic benefits for Canada.

Click HERE to apply